Postoperative radiotherapy results in 192 epithelial thymic tumours patients with 10 years of follow-up
Thymic epithelial tumours (TET) are rare and malignant tumours of the mediastinum. Due to their rarity, studies inclusion periods are long and treatment modalities have varied across time. Actual recommendations are not robust due to the lack of prospective studies. In addition, thymomas have a slow evolution and large series with a long-term follow-up are scarce [1 –5]. In France, treatment recommendations for the past 10 years, have been based on ESMO (European Society for Medical Oncology) and RYHTMIC (Réseau tumeurs THYMiques et Cancer), a French network mandated to systematically discuss every case of TET in France in a national or regional multidisci plinary tumour board (MTB) [6,7].
Source: Radiotherapy and Oncology - Category: Radiology Authors: Hugo Lopez, Angela Botticella, Farid Belkhir, Benjamin Besse, Elie Fadel, Olaf Mercier, Antonin Levy, C écile Le Péchoux Tags: Original Article Source Type: research